Ciprodex

Ciprodex is a brand name of ciprofloxacin/dexamethasone otic, approved by the FDA in the following formulation(s):

CIPRODEX (ciprofloxacin; dexamethasone - suspension/drops; otic)

• 
  Manufacturer: ALCON PHARMS LTD
  
  Approval date: July 18, 2003
  
  Strength(s): 0.3%;0.1% ^[RLD]

Has a generic version of Ciprodex been approved?

No. There is currently no therapeutically equivalent version of Ciprodex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ciprodex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Topical suspension formulations containing ciprofloxacin and dexamethasone
  Patent 6,284,804
  Issued: September 4, 2001
  Inventor(s): Singh; Onkar N. & Bhagat; Haresh G.
  Assignee(s): Alcon Universal Ltd.
  Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically stable and easily re-suspended. The formulations are intended for topical application to the eye, ear or nose.
  
  Patent expiration dates:
  
  
  • August 10, 2020
    
  
  



• 
  Topical suspension formulations containing ciprofloxacin and dexamethasone
  Patent 6,359,016
  Issued: March 19, 2002
  Inventor(s): Onkar N.; Singh & Haresh G.; Bhagat
  Assignee(s): Alcon Universal Ltd.
  Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically stable and easily re-suspended. The formulations are intended for topical application to the eye, ear or nose.
  
  Patent expiration dates:
  
  
  • August 10, 2020
    
  
  

See also...

• Ciprodex Consumer Information (Drugs.com)
• Ciprodex Consumer Information (Wolters Kluwer)
• Ciprodex Consumer Information (Cerner Multum)
• Ciprodex Advanced Consumer Information (Micromedex)
• Ciprofloxacin/Dexamethasone Consumer Information (Wolters Kluwer)
• Ciprofloxacin and dexamethasone otic Consumer Information (Cerner Multum)
• Ciprofloxacin and dexamethasone Otic Advanced Consumer Information (Micromedex)